Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$556.8M
Avg Funding
$22.3M
Global Reach
7
countries

Top Cities for Biopharma

Wilmington
Gebze
New York
Oxford
San Diego
Bethesda

Recently Funded Companies

Export
Wilmington, United States

DeepCyte is a biotechnology company that offers predictive products for toxicology using single-cell metabolomics technology.

$1.5M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Gebze, Turkey

PhiTech Bioinformatics provides AI-powered multi-omics based diagnostic decision support for precision medicine.

$2.4M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Gebze, Turkey

PhiTech Bioinformatics provides AI-powered multi-omics based diagnostic decision support for precision medicine.

$2.4M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Bond Biosciences is a biopharmaceutical company

$5.9M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Gebze, Turkey

PhiTech Bioinformatics provides AI-powered multi-omics based diagnostic decision support for precision medicine.

$2.4M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Gebze, Turkey

PhiTech Bioinformatics provides AI-powered multi-omics based diagnostic decision support for precision medicine.

$2.4M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Fermtech provides equipment for precision fermentation companies to scale production processes.

$3.3M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Oxeia Biopharmaceuticals is a clinical stage biotech company.

$1.5M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Bethesda, United States

Iyuda Therapeutics is a pharmaceutical therapeutics company developing treatments for oncological, infectious, and other immuno diseases.

$600K raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

$100.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Farmington Hills, United States

Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

$35.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Ponte Vedra Beach, United States

Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.

$2.5M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Stans, Switzerland

NewcelX is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

$1.4M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Ørsta, Norway

Arctic Bioscience is a biotech company that produces bioactive marine-based pharmaceutical and nutraceutical products and solutions.

$1.5M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Boulder, United States

Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.

$100.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Arch Biopartners acquires and develops products and technology for sale to pharmaceutical and industrial companies.

$432K raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Charlottetown, Canada

Our mission at Pegasus Biotech is to work with our clients to bring cutting edge innovation to the global human and animal health markets.

$360K raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Waltham, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

$100.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Carlsbad, United States

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

$3.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Wroclaw, Poland

Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases.

$17.7M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Doylestown, United States

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

$89.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.

$400K raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.

Mar 2026

Founder Contacts

41,000+ verified contacts

Lewes, United States

Halcyon Wellness is a biotechnology company that offers bioengineered liver health and wellness services.

$8.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

La Jolla, United States

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

$75.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Showing 151 to 175 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$22.3M
Total Funding Tracked
$556.8M
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Gebze
4 companies$9.6M
2.San Diego
2 companies$1.9M
3.Cambridge
2 companies$100.0M
4.Wilmington
1 companies$1.5M
5.New York
1 companies$5.9M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked